Thermo Fisher Scientific (NYSE: TMO) reported Q2 EPS of $5.51, $0.52 better than the analyst estimate of $4.99. Revenue for the quarter came in at $10.97 billion versus the consensus estimate of $9.97 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.